Walgreens announces price cuts on 1,300 items amid ongoing consumer spending fatigue

Walgreens announces price cuts on 1,300 items amid ongoing consumer spending fatigue


Signage is seen outside of a Walgreens, owned by the Walgreens Boots Alliance, Inc., in Manhattan, New York City, U.S., November 26, 2021. 

Andrew Kelly | Reuters

Walgreens announced Wednesday it would continue to cut prices on some 1,300 items — the latest company to pivot to value amid signs U.S. consumers are experiencing spending fatigue.

The pharmacy chain said in a statement announcing a “summer of savings” the lower prices were in response to consumers ongoing struggles with elevated inflation rates that continue to bedevil the U.S. economy.

“Walgreens understands our customers are under financial strain and struggle to purchase everyday essentials,” said Tracey D. Brown, EVP, President, Walgreens Retail & Chief Customer Officer. “We continue to be committed to our customers by lowering prices on over a thousand additional items, something we’ve been doing since October of 2023.”

Walgreens previously pointed to a “challenging” retail environment when it announced its quarterly earnings in March.

Among the price cuts highlighted by the company:

  • One a Day 80ct Men’s and Women’s Gummy Vitamins, now $11.99 (was $13.49)
  • Always Pad Mod Regular (20ct), now $6.99 (was $7.49)
  • Clean & Clear Foaming Facial Cleanser now $6.99, (was $7.99)
  • Eucerin Advance Repair Hand Cream now $5.99, (was $7.29)

Prices may be different based on your location.

Walgreens’ announcement follows others by retail giants that also indicate greater awareness of consumers’ price sensitivities. Last week, Target announced lower costs for thousands of items in its stores, while Walmart recently unveiled an entire new line of food items costing $5 or less.

The post-pandemic economic recovery is now showing signs of splitting into a ‘K’-shaped one, with more well-off Americans able to sustain consistent levels of spending, even amid inflation rates that continue to hover above 3%. Lower-income consumers have been cutting back more substantially.

In its monthly consumer confidence report, released yesterday, the Conference Board business group said those making over $100,000 per year expressed the largest rise in confidence and was overall at a higher level than those for lower-income groups.

“The lower-income consumer in the U.S. is stretched … [and] is strategizing a lot to make their budgets get to the end of the month,” PepsiCo CEO Ramon Laguarta told analysts on the company’s conference call in April.

Meanwhile, other areas of the economy more closely tied to wealthier consumers continue to outperform, especially travel. Even as American Airlines announced Wednesday it was cutting growth plans, analysts said the changes did not reflect a broader pullback.

“American’s diminished [outlook] speaks far more to its flawed initial forecast than any broad-based shift in passenger demand,” JPMorgan airline analyst Jamie Baker said in a note about the airline on Wednesday.



Source

Inside politics of broken, unaffordable U.S. health care, Cityblock CEO Toyin Ajayi sees opportunity
Health

Inside politics of broken, unaffordable U.S. health care, Cityblock CEO Toyin Ajayi sees opportunity

For the first time in decades, people are having real conversations about health care, “from the ground up,” says Dr. Toyin Ajayi. That has her feeling optimistic. “We’re in a moment where health and health care — and what it means to be healthy — is the subject of a national discussion,” the co-founder and […]

Read More
Il Makiage parent Oddity takes aim at Hims with new telehealth skincare platform Methodiq
Health

Il Makiage parent Oddity takes aim at Hims with new telehealth skincare platform Methodiq

Methodiq brand advertisement. Courtesy: Methodiq Il Makiage parent company Oddity is branching out into medical-grade skin care with its new brand Methodiq, as the online retailer looks to compete with Hims and help to address what it called a “broken medical care system.”  Methodiq, which has been in the works for four years and launched […]

Read More
Novo Nordisk cuts direct-to-consumer prices for Wegovy, Ozempic to 9 a month
Health

Novo Nordisk cuts direct-to-consumer prices for Wegovy, Ozempic to $349 a month

Boxes of Ozempic and Wegovy made by Novo Nordisk at a pharmacy in London on March 8, 2024. Hollie Adams | Reuters Novo Nordisk on Monday said it has cut the direct-to-consumer prices of its blockbuster weight loss drug Wegovy and diabetes counterpart Ozempic, adding to efforts by the company and the Trump administration to […]

Read More